1. Home
  2. About NIDDK
  3. Staff Directory
  4. Myrlene Staten, M.D.

Myrlene Staten, M.D.

Pharmacologic interventions and/or other medically related interventions to prevent or treat Type 2 Diabetes in adult patients

Responsibilities & Activities

As program director for diabetes translational research, I manage a portfolio of clinical translation and treatment studies for type 2 diabetes. My duties include serving as project scientist for the D2d study, which is designed to determine if vitamin D can reduce the risk for developing type 2 diabetes. I also participate in the Biomarkers’ Consortium, serving as chair of the Metabolic Diseases Steering Committee. The Biomarkers’ Consortium is a private-public partnership to support the development of biomarkers.

Committees & Working Groups

  • The Biomarkers Consortium for the Foundation for the NIH, Co-chair of Metabolic Diseases Committee
  • NIDDK Obesity Working Group, Member
  • NIDDK Diabetes Complications Working Group, Member